Catteruccia Lab
In the Catteruccia lab, we are motivated by our conviction that no one should suffer from malaria and other vector-borne diseases. We conduct rigorous science to advance this common goal, while fostering a safe and vibrant environment of intellectual curiosity, collaboration, equity, and inclusivity where any form of discrimination is wholly rejected.
651 Huntington Avenue
FXB Building, 3rd floor
Boston, MA 02115
Lab News
A heartfelt congratulations to Alli Probst on becoming Dr. Alli Probst! Last month, Dr. Probst completed her dissertation defense seminar, “Killing Plasmodium parasites in the mosquito: target identification and feasibility testing for a novel malaria control strategy.” We are thrilled for you on your incredible accomplishment!
Featured News
Flaminia Catteruccia elected member of National Academy of Sciences
Members are elected to the NAS in recognition of their distinguished and continuing achievements in original research, according to an April 30 release from the organization. Membership is a widely accepted mark of excellence in science and is considered one of the highest honors that a scientist can receive.
Watch the full Research Briefing Prof. Catteruccia gave at the NAS 162nd Annual Meeting (from 26:10sec)
Student Spotlight:
Malhar Khushu
(G3, Catteruccia/Wirth Lab)
Where are you from and what do you enjoy most about your hometown?
I was born and grew up in New Delhi, in India! It’s known for its rich history and richer food, and I miss the urban wildlife in and around where I grew up.
In the Media
-
In The Lab – May 2023
Welcome to “In the Lab” Spring into this month’s edition of “In the Lab”! This April and May, the Department of Immunology and Infectious Diseases newsletter explored Commencement, World Malaria…
-
Q&A with Esrah Du (G3, Catteruccia/Dvorin Labs)
Q&A with Esrah Du (G3, Catteruccia/Dvorin Labs) on their research and personal life
-
A multidisciplinary approach to eradicating malaria
Public health leaders from around the world gathered at Harvard University for a week-long course to learn the latest developments from experts and discuss new strategies for eradicating malaria.
-
A tech-centric approach to reducing mosquito-borne diseases
Hyegi Chung, MPH ’18, and former Harvard Chan postdoc Evdoxia Kakani met with students to talk about their work at Verily—a subsidiary of Alphabet, the parent company of Google—on using a tech-centric approach to reduce mosquito-borne diseases.
